MARKET

UTHR

UTHR

United Therapeutics Corp.
NASDAQ
511.72
-3.78
-0.73%
Pre Market: 510.00 -1.72 -0.34% 07:58 08/13 EDT
OPEN
510.44
PREV CLOSE
515.50
HIGH
521.43
LOW
506.01
VOLUME
17
TURNOVER
0
52 WEEK HIGH
609.35
52 WEEK LOW
292.34
MARKET CAP
21.95B
P/E (TTM)
18.30
1D
5D
1M
3M
1Y
5Y
1D
United Therapeutics (UTHR) Q2 2026 Earnings Call Transcript
The Motley Fool · 22h ago
3 ‘Perfect Ten’ Healthcare Stocks That Analysts Rate as a Strong Buy
TipRanks · 2d ago
Weekly Report: what happened at UTHR last week (0803-0807)?
Weekly Report · 3d ago
Stronger EPS, Ralinepag Progress, and Buybacks Might Change The Case For Investing In United Therapeutics (UTHR)
Simply Wall St · 6d ago
Buy Rating Reiterated on United Therapeutics as Diversified Pipeline Offsets Near-Term Headwinds; $660 Price Target Maintained
TipRanks · 6d ago
United Therapeutics Price Target Cut to $677.00/Share From $704.00 by RBC Capital
Dow Jones · 6d ago
United Therapeutics Is Maintained at Outperform by RBC Capital
Dow Jones · 6d ago
RBC Capital Maintains Outperform on United Therapeutics, Lowers Price Target to $677
Benzinga · 6d ago
More
About UTHR
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. It markets and sells commercial products, including Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI), Tyvaso (treprostinil) Inhalation Solution (Nebulized Tyvaso), Remodulin (treprostinil) Injection (Remodulin), Orenitram (treprostinil) Extended-Release Tablets (Orenitram), Unituxin (dinutuximab) Injection (Unituxin) and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and Nebulized Tyvaso to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). Unituxin, an infused monoclonal antibody for the treatment of high-risk neuroblastoma and for the treatment of neuroblastoma after high-dose chemotherapy. Adcirca, an oral immediate-release tablet form of the PDE-5 inhibitor tadalafil. Its THY-100 is in preclinical development for congenital athymia.

Webull offers United Therapeutics Corp stock information, including NASDAQ: UTHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UTHR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UTHR stock methods without spending real money on the virtual paper trading platform.